Silence Therapeutics Plc ADR
(SLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,057 | -44,464 | -31,560 | -46,277 | N/A |
| Depreciation Amortization | 587 | 464 | 351 | 637 | N/A |
| Accounts receivable | 37,792 | 37,629 | 40,352 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,307 | 1,341 | -452 | N/A | N/A |
| Other Working Capital | 53,416 | 41,378 | 42,197 | 23,956 | N/A |
| Other Operating Activity | -22,687 | -24,777 | -31,406 | 7,848 | 0 |
| Operating Cash Flow | $9,359 | $11,570 | $19,483 | $-13,836 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,803 | -1,007 | -633 | -652 | N/A |
| Purchase Of Investment | 13,751 | 6,420 | 3 | N/A | N/A |
| Purchase Sale Intangibles | -32 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -18 | 10 | 3 | 13,002 | 0 |
| Investing Cash Flow | $11,930 | $5,424 | $-628 | $12,350 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 42,521 | 39,703 | 43,195 | N/A | N/A |
| Other Financing Activity | -290 | -270 | -861 | 19,810 | 0 |
| Financing Cash Flow | $42,231 | $39,433 | $42,334 | $19,810 | $N/A |
| Exchange Rate Effect | -144 | 95 | 20 | -431 | N/A |
| Beginning Cash Position | 37,745 | 35,245 | 38,368 | 17,353 | N/A |
| End Cash Position | 101,121 | 91,766 | 99,577 | 35,245 | N/A |
| Net Cash Flow | $63,376 | $56,522 | $61,209 | $17,891 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,359 | 11,570 | 19,483 | -13,836 | N/A |
| Capital Expenditure | -1,803 | -1,007 | -633 | N/A | N/A |
| Free Cash Flow | 7,556 | 10,563 | 18,849 | -13,836 | 0 |